Xact Kapitalforvaltning’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$415K Hold
23,069
0.01% 845
2019
Q4
$409K Hold
23,069
0.01% 1091
2019
Q3
$358K Buy
23,069
+5,600
+32% +$92.2K 0.01% 1112
2019
Q2
$300K Hold
17,469
0.01% 1225
2019
Q1
$281K Sell
17,469
-12,100
-41% -$196K 0.01% 1253
2018
Q4
$433K Buy
29,569
+7,800
+36% +$124K 0.01% 989
2018
Q3
$396K Hold
21,769
0.01% 1141
2018
Q2
$367K Buy
21,769
+3,400
+19% +$64.3K 0.01% 1184
2018
Q1
$360K Buy
18,369
+3,800
+26% +$73.6K 0.01% 1071
2017
Q4
$295K Buy
+14,569
New +$268K 0.01% 961

Other funds holding HALO

Xact Kapitalforvaltning's HALO Position: Q1 2020 in Review

Xact Kapitalforvaltning held its Halozyme (HALO) position steady in Q1 2020 at 23,069 shares worth $415K. The position accounts for 0.01% of the portfolio, ranked #845.

Xact Kapitalforvaltning first reported a position in HALO in Q4 2017 and has held it in 10 quarters since. The position peaked at $433K in Q4 2018. 210 funds tracked by Wall St. Rank hold HALO as of Q1 2020.

  • Xact Kapitalforvaltning held 23,069 shares of Halozyme worth $415K as of Q1 2020.
  • Xact Kapitalforvaltning left its Halozyme share count unchanged in Q1 2020.
  • Halozyme made up 0.01% of Xact Kapitalforvaltning's portfolio in Q1 2020, its #845 holding.
  • Xact Kapitalforvaltning first reported a position in Halozyme in Q4 2017 and has held it in 10 quarters since.
  • Xact Kapitalforvaltning's Halozyme position peaked at $433K in Q4 2018.
  • 210 funds tracked by Wall St. Rank held Halozyme as of Q1 2020.

Based on Xact Kapitalforvaltning's 13F filing for Q1 2020, filed 14 May 2020.